trauma. Unspecified multiple injuries
Conditions
Interventions
Intervention 1: Intervention group: After enrollment and randomization, patients in this group will receive a single dose of intramuscular vitamin D3 300000 IU. Intervention 2: Control group: Patients
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with multiple trauma who are categorized as level 1 triage Patients who will admitted to the hospital within a maximum of 24 hours after trauma Patients who are 18 years old or older
Exclusion criteria
Exclusion criteria: Those who will not agree to enter the study and will not sign the informed consent form. Patients with chronic kidney disease or in need of dialysis Pregnant or lactating patients Patients with liver failure Those with thyroid and parathyroid diseases Patients on long-term steroid therapy or Cushing's syndrome Patients with sarcoidosis Patients with TB or silicosis Patients younger than 18 years old Patients with history of cancer within past 3 months Chemotherapy Patients with allergy to vitamin D supplements Patients with immunodeficiency diseases or on immunosuppressants within 1 week before hospital admission Obesity with BM I>35 kg/m2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hospital length of stay. Timepoint: from the randomization and enrollment to this study until the time of hospital discharge. Method of measurement: day count. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality. Timepoint: During the course of hospital admission. Method of measurement: Number of patients who die during the course of hospital admission. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHooman Rezaei
Shiraz University of Medical Sciences
Outcome results
None listed